{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:32:23Z","timestamp":1793057543437,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T00:00:00Z","timestamp":1382486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10157-013-0887-4","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T02:46:37Z","timestamp":1382409997000},"page":"214-217","source":"Crossref","is-referenced-by-count":30,"title":["Topics in lipoprotein glomerulopathy: an overview"],"prefix":"10.1007","volume":"18","author":[{"given":"Takao","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,23]]},"reference":[{"key":"887_CR1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0272-6386(89)80134-9","volume":"13","author":"T Saito","year":"1989","unstructured":"Saito T, Sato H, Kudo K, Oikawa S, Shibata T, Hara Y, et al. Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis. 1989;13:148\u201353.","journal-title":"Am J Kidney Dis"},{"key":"887_CR2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000185297","volume":"51","author":"Y Watanabe","year":"1989","unstructured":"Watanabe Y, Ozaki I, Yoshida F, Fukatsu A, Itoh Y, Matsuo S, et al. A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis. Nephron. 1989;51:265\u201370.","journal-title":"Nephron"},{"key":"887_CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ajkd.2005.10.017","volume":"47","author":"T Saito","year":"2006","unstructured":"Saito T, Matsunaga A, Oikawa S. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis. 2006;47:199\u2013211.","journal-title":"Am J Kidney Dis"},{"key":"887_CR4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0272-6386(12)80649-4","volume":"18","author":"S Oikawa","year":"1991","unstructured":"Oikawa S, Suzuki N, Sakuma E, Saito T, Namai K, Kotake H, et al. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy. Am J Kidney Dis. 1991;18:553\u20138.","journal-title":"Am J Kidney Dis"},{"key":"887_CR5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1681\/ASN.V85820","volume":"8","author":"S Oikawa","year":"1997","unstructured":"Oikawa S, Matsunaga A, Saito T, Sato H, Seki T, Hoshi K, et al. Apolipoprotein E Sendai (arginine145\u00a0\u2192\u00a0proline): a new variant associated with lipoprotein glomerulopathy. J Am Soc Nephrol. 1997;8:820\u20133.","journal-title":"J Am Soc Nephrol"},{"key":"887_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1523-1755.1999.00572.x","volume":"56","author":"A Matsunaga","year":"1999","unstructured":"Matsunaga A, Sasaki J, Komatsu T, Kanatsu K, Tsuji E, Moriyama K, et al. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. Kidney Int. 1999;56:421\u20137.","journal-title":"Kidney Int"},{"key":"887_CR7","doi-asserted-by":"crossref","unstructured":"Saito T, Matsunaga A. Lipoprotein glomerulopathy may provide a key to unlock the puzzles of renal lipidosis. Kidney Int 2013 (in press).","DOI":"10.1038\/ki.2013.404"},{"key":"887_CR8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/jhg.2013.8","volume":"58","author":"K Toyota","year":"2013","unstructured":"Toyota K, Hashimoto T, Ogino D, Matsunaga A, Ito M, Masakane I, et al. A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy. J Hum Genet. 2013;58:254\u20138.","journal-title":"J Hum Genet"},{"key":"887_CR9","doi-asserted-by":"crossref","unstructured":"Hu Z, Huang S, Wu Y, Liu Y, Liu X, Su D, et al. Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation. Kidney Int 2013 [Epub ahead of print].","DOI":"10.1038\/ki.2013.335"},{"key":"887_CR10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1681\/ASN.V123524","volume":"12","author":"M Hoffmann","year":"2001","unstructured":"Hoffmann M, Scharnagl H, Panagiotou E, Banghard W, Wieland H, M\u00e4rz W. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy. J Am Soc Nephrol. 2001;12:524\u201330.","journal-title":"J Am Soc Nephrol"},{"key":"887_CR11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1194\/jlr.M030965","volume":"54","author":"D Georgiadou","year":"2013","unstructured":"Georgiadou D, Stamatakis K, Efthimiadou EK, Kordas G, Gantz D, Chroni A, et al. Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy. J Lipid Res. 2013;54:164\u201376.","journal-title":"J Lipid Res"},{"key":"887_CR12","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1186\/1752-1947-3-9311","volume":"3","author":"G Russi","year":"2009","unstructured":"Russi G, Furci L, Leonelli M, Magistroni R, Romano N, Rivasi P, et al. Lipoprotein glomerulopathy treated with LDL-apheresis (heparin-induced extracorporeal lipoprotein precipitation system): a case report. J Med Case Rep. 2009;3:9311.","journal-title":"J Med Case Rep"},{"key":"887_CR13","doi-asserted-by":"crossref","first-page":"31269","DOI":"10.1074\/jbc.M005906200","volume":"275","author":"Y Ishigaki","year":"2000","unstructured":"Ishigaki Y, Oikawa S, Suzuki T, Usui S, Magoori K, Kim DH, et al. Virus-mediated transduction of apolipoprotein E (ApoE)-Sendai develops lipoprotein glomerulopathy in ApoE-deficient mice. J Biol Chem. 2000;275:31269\u201373.","journal-title":"J Biol Chem"},{"key":"887_CR14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10157-009-0195-1","volume":"13","author":"A Ishimura","year":"2009","unstructured":"Ishimura A, Watanabe M, Nakashima H, Ito K, Miyake K, Mochizuki S, et al. Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice. Clin Exp Nephrol. 2009;13:430\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"887_CR15","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/01.ASN.0000015615.14428.67","volume":"13","author":"Y Kanamaru","year":"2002","unstructured":"Kanamaru Y, Nakao A, Shirato I, Okumura K, Ogawa H, Tomino Y, et al. Chronic graft-versus-host autoimmune disease in Fc receptor gamma chain-deficient mice results in lipoprotein glomerulopathy. J Am Soc Nephrol. 2002;13:1527\u201333.","journal-title":"J Am Soc Nephrol"},{"key":"887_CR16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10157-011-0554-6","volume":"16","author":"Y Miyahara","year":"2012","unstructured":"Miyahara Y, Nishimura S, Watanabe M, Ito K, Nakashima H, Saito T. Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy. Clin Exp Nephrol. 2012;16:115\u201321.","journal-title":"Clin Exp Nephrol"},{"key":"887_CR17","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1093\/ndt\/gfs329","volume":"27","author":"K Ito","year":"2012","unstructured":"Ito K, Nakashima H, Watanabe M, Ishimura A, Miyahara Y, Abe Y, et al. Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities. Nephrol Dial Transplant. 2012;27:3899\u2013907.","journal-title":"Nephrol Dial Transplant"},{"key":"887_CR18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/ndt\/gfn555","volume":"24","author":"Z Xin","year":"2009","unstructured":"Xin Z, Zhihong L, Shijun L, Jinfeng Z, Huiping C, Caihong Z, et al. Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption: a pilot study. Nephrol Dial Transplant. 2009;24:864\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"887_CR19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.bi.52.070183.001255","volume":"52","author":"MS Brown","year":"1983","unstructured":"Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223\u201361.","journal-title":"Annu Rev Biochem"},{"key":"887_CR20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000059838","volume":"120","author":"SD Ricardo","year":"1997","unstructured":"Ricardo SD, van Goor H, Diamond JR. Hypercholesterolemia and progressive kidney disease: the role of macrophages and macrophage-derived products. Contrib Nephrol. 1997;120:197\u2013209.","journal-title":"Contrib Nephrol"},{"key":"887_CR21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000045511","volume":"83","author":"T Saito","year":"1999","unstructured":"Saito T, Oikawa S, Sato H, Sasaki J. Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants. Nephron. 1999;83:193\u2013201.","journal-title":"Nephron"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0887-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-013-0887-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0887-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T21:16:58Z","timestamp":1646860618000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-013-0887-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,23]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s10157-013-0887-4","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,23]]}}}